Terms: = Kidney tumors AND KMT2D, ENSG00000167548, 8085, MLL2 AND Prognosis
3 results:
1. Comparison and validation of different risk models for papillary renal cell carcinoma.
Lin H; Sun Q; Li Z; Zheng J; Zhang X; Xiong Y; Chen H; Hou Y; Xi W; Lin J
Urol Oncol; 2023 Aug; 41(8):358.e1-358.e7. PubMed ID: 37394414
[TBL] [Abstract] [Full Text] [Related]
2. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
[TBL] [Abstract] [Full Text] [Related]
3. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation.
Dusseux E; Albano L; Fafin C; Hourmant M; Guérin O; Couchoud C; Moranne O
Kidney Int; 2015 Jul; 88(1):121-9. PubMed ID: 25671769
[TBL] [Abstract] [Full Text] [Related]
